Mano Horinaka

2.7k citations
66 papers · 2.1k indexed · h-index 25
Topics
Cell death mechanisms and regulation (19 papers)Histone Deacetylase Inhibitors Research (11 papers)RNA Interference and Gene Delivery (7 papers)
Partner nations
JapanUnited StatesEgypt

In The Last Decade

Mano Horinaka

64 papers receiving 2.0k citations

Peers

Mano Horinaka
Comparison fields: 5 of 101
  • Molecular Biology 1.5k
  • Oncology 424
  • Cancer Research 386
  • Immunology 306
  • Pharmacology 199
Replace Tatsushi Yoshida with:
Tatsushi Yoshida Japan
Hyen Joo Park South Korea
Dharmalingam Subramaniam United States
Miki Wakada Japan
Dexin Kong China
Shenghua Zhang China
Claudia Ceci Italy
Alessia Garufi Italy
Numsen Hail United States
Jen‐Yang Tang Taiwan
Mano Horinaka relative to Tatsushi Yoshida Japan Tatsushi Yoshida's profile →
Citations per field
00.5×1.6×
Tatsushi Yoshida · 1×
Citations per year

Countries citing papers authored by Mano Horinaka

Since Specialization
Citations

This map shows the geographic impact of Mano Horinaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mano Horinaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mano Horinaka more than expected).

Fields of papers citing papers by Mano Horinaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mano Horinaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mano Horinaka. The network helps show where Mano Horinaka may publish in the future.

Co-authorship network of co-authors of Mano Horinaka

This figure shows the co-authorship network connecting the top 25 collaborators of Mano Horinaka. A scholar is included among the top collaborators of Mano Horinaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mano Horinaka. Mano Horinaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 9
3 3
4 4
5 11
6 0
7 5
8 5
9 3
10 6
11 8
12 12
13 12
14 3
15 32
16 10
17 23
18 12
19 100
20 43

About Mano Horinaka

Mano Horinaka is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 66 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (19 papers), Histone Deacetylase Inhibitors Research (11 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Cancer Research (386 citations), Molecular Biology (1.5k citations) and Biochemistry (98 citations). Mano Horinaka has collaborated with scholars based in Japan, United States and Egypt. Frequent co-authors include Toshiyuki Sakai, Tatsushi Yoshida, Miki Wakada, Takumi Shiraishi, Susumu Nakata, Tsuneharu Miki, Takashi Yasuda, Yoichi Mizutani, Ahmed E. Goda and Hoyoku Nishino. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026